1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sustained efficacy and safety with asciminib (ASC) after almost 4 years of median follow-up from ASCEMBL, a phase 3 study of ASC vs bosutinib (BOS) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 prior tyrosine kinase inhibitors (TKIs): An end of study treatment (EOS Tx) update, including results from switch population
    Meeting Abstract

    Mauro, M.; Minami, Y.; Hochhaus, A.; Lomaia, E.; Voloshin, S.; Turkina, A.; Kim, D. W.; Apperley, J. F.; Cortes, J.; Abdo, A. N. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CNS prophylaxis in adult ALL patients after stem cell transplantation: An EBMT survey on general practice
    Meeting Abstract

    Chiusolo, P.; Labopin, M.; Khvedelidze, I.; Baron, F.; Brissot, E.; Bazarbachi, A.; Bug, G.; Esteve, J.; Giebel, S.; Gorin, N. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PET4 response as an independent predictor of long-term outcomes in ECHELON2 (A+CHP vs. CHOP) in CD30+PTCL
    Meeting Abstract

    Iyer, S. P.; Mehta-Shah, N.; Advani, R. H.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domenech, E. D.; Pagani, C.; Kim, W. S.; Alpdogan, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Hepatic response and progression criteria in light chain amyloidosis: A multicenter validation study
    Meeting Abstract

    Muchtar, E.; Palladini, G.; Schonland, S.; Dispenzieri, A.; Wisniowski, B.; Merlini, G.; Milani, P.; Hegenbart, U.; Dittrich, T.; Kastritis, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dose escalation of ISB 1342, a novel CD38xCD3 bispecific antibody, in patients with relapsed / refractory multiple myeloma (RRMM)
    Meeting Abstract

    Kapoor, P.; Stevens, D. A.; Leleu, X.; Merzoug, K. B.; Karlin, L.; Manier, S.; Chalopin, T.; Hulin, C.; Perrot, A.; Berdeja, J. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • HJKC3-0006: Outcome of patients with CML treated on second line or later therapy in routine clinical practice
    Meeting Abstract

    Thompson, J. E.; Gao, Y.; Visotcky, A.; Flynn, K. E.; Mauro, M.; Giever, E.; Baim, A.; Akinola, I.; Larson, R.; Jamy, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world tisagenlecleucel outcomes in Richter-transformed chronic lymphocytic leukemia: A Center for International Blood & Marrow Transplant Research (CIBMTR) analysis
    Meeting Abstract

    Shadman, M.; Frigault, M. J.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Landsburg, D. J.; Ram, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell (CAR-T) therapy in secondary central nervous system large B-cell lymphoma (SCNSL): A multicenter retrospective analysis
    Meeting Abstract

    Ahmed, G.; Alsouqi, A.; Szabo, A.; Rojek, A. E.; Riedell, P. A.; Awan, F. T.; Samples, L.; Shadman, M.; Hu, M.; Bachanova, V.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): Analysis of cytopenias and infections in pts from KarMMa-3
    Meeting Abstract

    Baz, R.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K. K.; Nooka, A. K.; Costa, L.; Raje, N. S.; Abrahamsen, I. W.; Delforge, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • HJKC3-007: Outcomes of patients with chronic myeloid leukemia in chronic phase treated with asciminib and other tyrosine kinase inhibitors in routine clinical practice
    Meeting Abstract

    Mauro, M.; Atallah, E. L.; Thompson, J. E.; Gao, Y.; Visotcky, A.; Giever, E.; Baim, A.; Akinola, I.; Larson, R. A.; Jamy, O.; more...
    Blood (2023)

    Fulltext@MSK | Save